LAURA LAMBERT: Open Payments
NPI 1639546443 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 50 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $744 · 2025 $1,226
Food & beverage: $1,132Education: $94
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $242 |
| ABBVIE INC. | 10 | $232 |
| Janssen Biotech, Inc. | 6 | $173 |
| AstraZeneca Pharmaceuticals LP | 2 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $95 |
| PFIZER INC. | 3 | $63 |
| Grifols USA, LLC | 2 | $53 |
| Bioventus LLC | 1 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
Products named: TREMFYA, SKYRIZI, KRYSTEXXA, SAPHNELO, COSENTYX, RINVOQ, XELJANZ, Gamunex-C.
Industry payments across MD — which companies pay providers there.
